Condition: Bronchiolitis · Sponsor: Children's Hospital of Soochow University
This is a multicenter, randomized, positive-controlled, non-inferiority clinical study, planning to enroll 90 children with bronchiolitis caused by respiratory syncytial virus infection, to evaluate the safety and efficacy of inhaled Peginterferon α-2b injection compared to recombinant human interferon α2b in the treatment of pediatric respiratory syncytial virus bronchiolitis.
This description comes directly from the study's public registry record.
Chuangli Hao, Ph.D · 13771905555 · hcl_md@163.com
Always discuss trial participation with your own doctor first.
| Wuhan Women and Children's Health Care Center | Wuhan, Hubei, China | Not Yet Recruiting |
| Children's Hospital of Soochow University | Suzhou, Jiangsu, China | Recruiting |
| The First Hospital of Jilin University | Changchun, Jilin, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06827249